[ad_1] Ambrx Biopharma Inc AMAM announced preliminary safety and efficacy data from its Phase 2 ACE‑Breast-03 study. The data presented demonstrated a 51.7% overall response rate (ORR) and 100% disease control…
[ad_1] BTIG upgraded Aerovate Therapeutics Inc AVTE from Neutral to Buy with a price target of $27. The analyst writes that to Aerovate’s benefit, Gossamer Bio Inc‘s GOSS TORREY Phase 2 results validated dry powder…
[ad_1] Akeso Inc announced a collaboration and license agreement with Summit Therapeutics Inc SMMT to out-license its breakthrough bispecific antibody, ivonescimab (PD-1/VEGF, AK112) for development and commercialization in the U.S., Canada, Europe, and Japan. …
[ad_1] Adidas AG (OTC: ADDYY) ADDDF initiated a probe into allegations of inappropriate behavior by Kanye West after receiving an anonymous letter making several allegations. The investigation follows a report…
[ad_1] Volkswagen AG VWAGY VWAPY said that despite some sales gains in recent months, it expects its market share in China to be around 16% this year, down from 20%…
[ad_1] Deere & Company DE has reported Q4 FY 22 sales of $15.54 billion, beating the consensus of $13.39 billion. The company sold out of large tractors in Q3 due to parts shortages.…
[ad_1] CEL-SCI Corporation CVM said that its 10-year Phase 3 trial showed that Multikine immunotherapy significantly extended the lives of patients with locally advanced primary squamous cell carcinoma of the head and…
[ad_1] OKYO Pharma Limited OKYO filed an Investigational New Drug (IND) application with the FDA for the development of OK-101 to treat dry eye disease (DED). Both nonclinical and clinical…
[ad_1] CNBC Despite NATO Coming In Support Of Ukraine, Kyiv Asserts It Does Not Take Blame For Poland Missile Attack Ukraine’s President Volodymyr Zelenskyy said that his top military…
[ad_1] British Prime Minister Rishi Sunak extended his support for Ukraine at the G20 summit while confirming a long-planned order for warships from BAE Systems plc BAESY BAESF. “Russia’s actions…
[ad_1] At a G-20 meeting, a $20 billion funding plan was announced aimed at helping Indonesia, the world’s largest coal exporter, adopt renewable energy sources. Developed countries, including the U.S.…
[ad_1] The FDA has issued a notice regarding the safety and effectiveness of certain naloxone hydrochloride products for nonprescription or over-the-counter (OTC) use. Naloxone is a medicine that can help…
[ad_1] Neoleukin Therapeutics Inc NLTX announced discontinuing the development of NL-201 for strategic reasons. Preliminary monotherapy data from the Phase 1 study of NL-201 did not demonstrate significant immunogenicity even after…
[ad_1] RBC Capital Markets initiated coverage on Outset Medical Inc OM with an Outperform rating and a price target of $23. The analyst writes that Outset Medical is a medical device company…
[ad_1] GSK plc’s GSK DREAMM-3 Phase 3 head-to-head superiority trial of Blenrep (belantamab mafodotin) for relapsed or refractory multiple myeloma (RRMM) did not meet its primary endpoint of progression-free survival (PFS). …
[ad_1] Penumbra Inc PEN posted Q3 FY22 revenue of $213.7 million, +12.4% Y/Y (up 15.1% in constant currency), beating the consensus of $212.28 million. Revenue from sales of vascular products…
[ad_1] Teva Pharmaceutical Industries Ltd’s TEVA Q3 sales reached $3.59 billion, shrinking 8% Y/Y, missing the consensus of $3.83 billion. The decrease is mainly due to lower revenues from generic…
[ad_1] iRhythm Technologies Inc IRTC posted an adjusted EPS loss of $(0.63), better than $(0.81) a year ago and the consensus of $(0.83). The wearable heart monitor developer recorded sales…
[ad_1] Hologic Inc HOLX posted Q4 adjusted EPS of $0.82, down from $1.61 a year ago and beating the consensus of $0.63. Revenue of $953.3 million decreased 27.6% Y/Y (down…
[ad_1] Hoth Therapeutics Inc HOTH announced Phase 1b trial data for BioLexa in adult patients with mild-to-moderate atopic dermatitis. Using the SCORAD as a clinical tool for assessing the…
[ad_1] Airbus SE EADSY is reportedly negotiating a new bribery settlement with French authorities over past dealings in Libya and Kazakhstan in addition to fines agreed in 2020. The…
[ad_1] Tricida Inc TCDA announced the topline results from its VALOR-CKD renal outcomes clinical trial, designed to evaluate veverimer’s ability to slow chronic kidney disease (CKD) progression. The VALOR-CKD trial did…
[ad_1] Credit Suisse Group AG CS has reached a settlement with the Parquet National Financier (PNF) to resolve a legacy matter concerning an investigation into historical cross-border private-banking services. The settlement…
[ad_1] Saudi Arabia is reportedly negotiating with Airbus SE EADSY EADSF to order almost 40 A350 jets. According to industry sources, the country is planning to launch a new airline…
[ad_1] Earlier today, the FDA requested additional data to allow a 12-week portion of the Phase 2 PIVOT-HD study evaluating PTC Therapeutics Inc’s PTCT PTC518 for Huntington’s disease. The additional requirement…